Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78149

1.

Drug Effects on the Thyroid. Reply.

Burch HB.

N Engl J Med. 2019 Nov 14;381(20):1980-1981. doi: 10.1056/NEJMc1912672. No abstract available.

PMID:
31722169
2.

Drug Effects on the Thyroid.

Angus L, Peeters RP, van der Veldt AAM.

N Engl J Med. 2019 Nov 14;381(20):1980. doi: 10.1056/NEJMc1912672. No abstract available.

PMID:
31722168
3.

Drug Effects on the Thyroid.

Abualia M, Amarin JZ, Zayed AA.

N Engl J Med. 2019 Nov 14;381(20):1979-1980. doi: 10.1056/NEJMc1912672. No abstract available.

PMID:
31722167
4.

Drug Effects on the Thyroid.

Lin HY, Lin SF.

N Engl J Med. 2019 Nov 14;381(20):1979. doi: 10.1056/NEJMc1912672. No abstract available.

PMID:
31722166
5.

Measles.

Rawlinson WD, Palasanthiran P.

N Engl J Med. 2019 Nov 14;381(20):1978-1979. doi: 10.1056/NEJMc1912468. No abstract available.

PMID:
31722165
6.

Measles.

Oncel I, Anlar B, Yalaz K.

N Engl J Med. 2019 Nov 14;381(20):1978. doi: 10.1056/NEJMc1912468. No abstract available.

PMID:
31722164
7.

Selinexor for Refractory Multiple Myeloma. Reply.

Chari A, Vogl DT, Jagannath S.

N Engl J Med. 2019 Nov 14;381(20):1977-1978. doi: 10.1056/NEJMc1912625. No abstract available.

PMID:
31722163
8.

Selinexor for Refractory Multiple Myeloma.

Jhaveri KD, Wanchoo R.

N Engl J Med. 2019 Nov 14;381(20):1977. doi: 10.1056/NEJMc1912625. No abstract available.

PMID:
31722162
9.

Watched by Apple.

Campion EW, Jarcho JA.

N Engl J Med. 2019 Nov 14;381(20):1964-1965. doi: 10.1056/NEJMe1913980. No abstract available.

PMID:
31722159
10.

On the "Take" as a Biomarker.

Baden LR, Damon IK.

N Engl J Med. 2019 Nov 14;381(20):1962-1963. doi: 10.1056/NEJMe1913048. No abstract available.

PMID:
31722158
11.

The "All of Us" Research Program.

Murray J.

N Engl J Med. 2019 Nov 7;381(19):1884. doi: 10.1056/NEJMc1912496. No abstract available.

PMID:
31693825
12.

The "All of Us" Research Program.

Sullivan F, McKinstry B, Vasishta S.

N Engl J Med. 2019 Nov 7;381(19):1883-1884. doi: 10.1056/NEJMc1912496. No abstract available.

PMID:
31693824
13.

Pheochromocytoma and Paraganglioma. Reply.

Neumann HPH, Young WF Jr, Eng C.

N Engl J Med. 2019 Nov 7;381(19):1883. doi: 10.1056/NEJMc1912022. No abstract available.

PMID:
31693823
14.

Pheochromocytoma and Paraganglioma.

Tassone F.

N Engl J Med. 2019 Nov 7;381(19):1882-1883. doi: 10.1056/NEJMc1912022. No abstract available.

PMID:
31693822
15.

Pheochromocytoma and Paraganglioma.

Whitelaw BC, Mustafa OG, Prague JK.

N Engl J Med. 2019 Nov 7;381(19):1882. doi: 10.1056/NEJMc1912022. No abstract available.

PMID:
31693821
16.

Warm Autoimmune Hemolytic Anemia. Reply.

Brodsky RA.

N Engl J Med. 2019 Nov 7;381(19):1881-1882. doi: 10.1056/NEJMc1912352. No abstract available.

PMID:
31693820
17.

Warm Autoimmune Hemolytic Anemia.

Shvidel L, Stanevsky A, Sigler E.

N Engl J Med. 2019 Nov 7;381(19):1881. doi: 10.1056/NEJMc1912352. No abstract available.

PMID:
31693819
18.

Teplizumab in Relatives at Risk for Type 1 Diabetes. Reply.

Herold KC, Bundy BN, Krischer JP; Type 1 Diabetes TrialNet Study Group.

N Engl J Med. 2019 Nov 7;381(19):1880-1881. doi: 10.1056/NEJMc1912500. No abstract available.

PMID:
31693818
19.

Teplizumab in Relatives at Risk for Type 1 Diabetes.

Korsgren O, Skog O, Ludvigsson J.

N Engl J Med. 2019 Nov 7;381(19):1879-1880. doi: 10.1056/NEJMc1912500. No abstract available.

PMID:
31693817
20.

Teplizumab in Relatives at Risk for Type 1 Diabetes.

Couri CE, Malmegrim KCR, Oliveira MC.

N Engl J Med. 2019 Nov 7;381(19):1879. doi: 10.1056/NEJMc1912500. No abstract available.

PMID:
31693816

Supplemental Content

Loading ...
Support Center